Status:
RECRUITING
Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial
Lead Sponsor:
Medical University of Warsaw
Conditions:
Liver Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The study aims to evaluate the effect of the hemostatic matrix with fibrinogen and thrombin (TachoSil®) on vena cava inferior anastomoses during liver transplantation from a deceased donor. The resea...
Detailed Description
Studies have shown that materials containing fibrin shorten the time to hemostasis in the case of planned liver resection, but did not show a significant effect on the occurrence of postoperative blee...
Eligibility Criteria
Inclusion
- age over 18
- elective liver transplantation
- informed consent to participate in the study
Exclusion
- decision to use packing during liver transplantation (bail out strategy)
Key Trial Info
Start Date :
November 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT06124209
Start Date
November 4 2023
End Date
March 1 2026
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of General Transplant and Liver Surgery
Warsaw, Mazovian Voivodeship, Poland, 02-097